Yao Y - Search Results

1

CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma.

Yao Y, Ng JF, Park WD, Samur M, Morelli E, Encinas Mayoral J, Chyra Z, Xu Y, Derebail S, Epstein C, Nabet B, Chesi M, Gray NS, Young RA, Kwiatkowski N, Mitsiades C, Anderson KC, Lin CY, Munshi NC, Fulciniti M. Yao Y, et al. Blood. 2023 Jun 8;141(23):2841-2852. doi: 10.1182/blood.2022018885. Blood. 2023. PMID: 36877894 Free PMC article.

2

Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.

Du T, Song Y, Ray A, Wan X, Yao Y, Samur MK, Shen C, Penailillo J, Sewastianik T, Tai YT, Fulciniti M, Munshi NC, Wu H, Carrasco RD, Chauhan D, Anderson KC. Du T, et al. Among authors: yao y. Blood. 2023 May 25;141(21):2599-2614. doi: 10.1182/blood.2022017897. Blood. 2023. PMID: 36630605 Free PMC article.

3

Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies.

Deng S, Derebail S, Weiler VJ, Fong Ng J, Maroto-Martin E, Chatterjee M, Giorgetti G, Chakraborty C, Kalhotra P, Du T, Yao Y, Prabhala R, Shammas M, Gulla A, Aktas Samur A, Samur MK, Qiu L, Anderson KC, Fulciniti M, Munshi NC. Deng S, et al. Among authors: yao y. Blood Adv. 2024 Aug 13;8(15):4025-4034. doi: 10.1182/bloodadvances.2023012298. Blood Adv. 2024. PMID: 38861273 Free PMC article.

4

Unlocking the therapeutic potential of selective CDK7 and BRD4 Inhibition against multiple myeloma cell growth.

Yao Y, Deng S, Ng JF, Yuan M, Chakraborty C, JoyWeiler V, Munshi N, Fulciniti M. Yao Y, et al. Haematologica. 2024 Jul 25. doi: 10.3324/haematol.2024.285491. Online ahead of print. Haematologica. 2024. PMID: 39049606 Free article.

5

Internet use and mental wellbeing in older adults.

Yao Y, Dong E. Yao Y, et al. Nat Hum Behav. 2024 Nov 18. doi: 10.1038/s41562-024-02050-z. Online ahead of print. Nat Hum Behav. 2024. PMID: 39558111 No abstract available.

6

Caricature-visual face recognition based on jigsaw solving and modal decoupling.

Yao Y, Wang C. Yao Y, et al. Sci Rep. 2024 Nov 18;14(1):28419. doi: 10.1038/s41598-024-80032-x. Sci Rep. 2024. PMID: 39558061

7

METTL14-mediated m⁶A modification enhances USP22-ERα axis to drive breast cancer malignancy.

Zhuang X, Yin S, Cheng J, Sun W, Fang Z, Xiang Y, Peng EY, Yao Y, Li Y, He X, Lu L, Deng Y, Huang H, Cai G, Liao Y. Zhuang X, et al. Among authors: yao y. Pharmacol Res. 2024 Nov 16:107509. doi: 10.1016/j.phrs.2024.107509. Online ahead of print. Pharmacol Res. 2024. PMID: 39557350

8

Iron-Catalyzed Perfluoroalkylarylation of Styrenes with Arenes and Alkyl Iodides Enabled by Halogen Atom Transfer.

Zhao HQ, Li WT, Yao Y, Zhao YL, Ouyang XH. Zhao HQ, et al. Among authors: yao y. Org Lett. 2024 Nov 18. doi: 10.1021/acs.orglett.4c04095. Online ahead of print. Org Lett. 2024. PMID: 39556037

9

Optimizing Reversible Phase-Transformation of FeS₂ Anode via Atomic-Interface Engineering Toward Fast-Charging Sodium Storage: Theoretical Predication and Experimental Validation.

Zhao W, Zhou Y, Zhou H, Wang X, Sun S, He X, Luo Y, Ying B, Yao Y, Ma X, Sun X. Zhao W, et al. Among authors: yao y. Adv Sci (Weinh). 2024 Nov 18:e2411884. doi: 10.1002/advs.202411884. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39555728

10

Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning.

Zhu L, Yao Y. Zhu L, et al. Among authors: yao y. Front Immunol. 2024 Nov 1;15:1445618. doi: 10.3389/fimmu.2024.1445618. eCollection 2024. Front Immunol. 2024. PMID: 39555074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,290 results

Search Page

Filters